Abstract: A system includes: a first converter for receiving a pre-stage input DC voltage from a power source, and providing a pre-stage output DC voltage including a first DC voltage or a second DC voltage; a modulator the modulator controlling the first converter; a second converter, coupled to the first converter; and a controller, the controller controlling an operation mode of the second converter and notifying the modulator about the operation mode of the second converter. The modulator and the controller receive an external voltage indication signal indicating whether the pre-stage output DC voltage is the first DC voltage or the second DC voltage. The modulator controls the first converter to output the pre-stage output DC voltage based on the voltage indication signal. The modulator notifies the controller about whether the pre-stage output DC voltage reaches a target level.

Abstract: The preset invention provides a frame structure, a display device with the frame structure, and a method of fabricating the display device. The frame structure includes a first frame and a second frame. The first frame includes two lateral portions opposite to each other, and a top portion and a bottom portion opposite to each other. A first engaging component is disposed on the lateral portion. The second frame is disposed around the first frame. The second frame includes a top plank and two lateral planks. The top plank is disposed corresponding to the top portion, and the lateral plank is disposed corresponding to the lateral portion. A second engaging component is disposed on the lateral plank. The second engaging component is slidably engaged with the first engaging component. Thus, the present invention can decrease thickness of the frame structure and the display device for preferable aesthetic and low cost.

Abstract: The present invention provides a method for treating, preventing or reducing peritoneal fibrosis comprising administering to a subject in need thereof a pharmacologically effective dose of a type I cannabinoid receptor (CB1R) antagonist or a type II cannabinoid receptor (CB2R) agonist. Also provided is a dialysis fluid for treating, preventing or reducing peritoneal fibrosis comprising electrolytes, an osmotic agent, a physiologically acceptable pH solution, and a pharmacologically effective dose of a CB1R antagonist or a CB2R agonist.

Abstract: A system includes: a first converter for receiving a pre-stage input DC voltage from a power source, and providing a pre-stage output DC voltage including a first DC voltage or a second DC voltage; a modulator the modulator controlling the first converter; a second converter, coupled to the first converter; and a controller, the controller controlling an operation mode of the second converter and notifying the modulator about the operation mode of the second converter. The modulator and the controller receive an external voltage indication signal indicating whether the pre-stage output DC voltage is the first DC voltage or the second DC voltage. The modulator controls the first converter to output the pre-stage output DC voltage based on the voltage indication signal. The modulator notifies the controller about whether the pre-stage output DC voltage reaches a target level.

Abstract: An edge type light source module has at least one middle light emitting region and edge light emitting region and includes a first edge type light emitting device and a second edge type light emitting device. If the middle light emitting region is a lighting region having a brightness value L1, the edge light emitting region adjacent to the lighting region is a light leakage region. The light leakage region has a predetermined brightness value L2, and a compensation brightness value L2? of the light leakage region satisfies L2?=L2?(L1*k1*R1), 0?k1?1, and 20%?R1?60%. If the edge light emitting region is a lighting region having a brightness value L3, the middle light emitting region adjacent to the lighting region is a light leakage region. The light leakage region has a predetermined brightness value L4, and a compensation brightness value L4? of the light leakage region satisfies L4?=L4?(L3*k2*R2), 0?k2?1, and 10%?R2?50%.

Abstract: An edge type light source module has at least one middle light emitting region and edge light emitting region and includes a first edge type light emitting device and a second edge type light emitting device. If the middle light emitting region is a lighting region having a brightness value L1, the edge light emitting region adjacent to the lighting region is a light leakage region. The light leakage region has a predetermined brightness value L2, and a compensation brightness value L2? of the light leakage region satisfies L2?=L2?(L1*k1*R1), 0?k1?1, and 20%?R1?60%. If the edge light emitting region is a lighting region having a brightness value L3, the middle light emitting region adjacent to the lighting region is a light leakage region. The light leakage region has a predetermined brightness value L4, and a compensation brightness value L4? of the light leakage region satisfies L4?=L4?(L3*k2*R2), 0?k2?1, and 10%?R2?50%.

Abstract: A buck-store and boost-restore converter is to be electrically connected to a pre-stage circuit, which provides a pre-stage output direct current (DC) voltage to a first capacitive load. The converter has an inductance element and is to be electrically connected to a second capacitive load. When the pre-stage output DC voltage is reduced from a first DC voltage to a second DC voltage, the inductance element outputs a current to the second capacitive load so as to transfer electric energy, which is stored in the first capacitive load, to the second capacitive load. When the pre-stage output DC voltage is raised from the second DC voltage to the first DC voltage, the inductance element outputs a current to the first capacitive load so as to transfer electric energy, which is stored in the second capacitive load, to the first capacitive load.